Legal Representation
Attorney
Jill Anderfuren
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 28, 2013 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 28, 2013 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 17, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 15, 2013 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 15, 2013 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 15, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 25, 2012 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 31, 2012 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 31, 2012 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 11, 2012 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 22, 2012 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jun 21, 2012 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 5, 2012 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 31, 2012 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 31, 2012 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 31, 2012 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 2, 2011 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Dec 2, 2011 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Dec 2, 2011 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Nov 30, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 12, 2011 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 11, 2011 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Nutritional supplements, vitamin supplements; pharmaceutical preparations for the treatment of diseases and disorders of the parathyroid, secondary hyper-parathyroidism, and renal disease; Preparations for the treatment of vitamin D deficiency
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005